[{"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":99626000.0,"EarningsPerShareBasic_1_Q1_USD":0.29,"StockholdersEquity_0_Q1_USD":581626000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":51806000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":52780000.0,"NetIncomeLoss_1_Q1_USD":15237000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":16082000.0,"CommonStockSharesOutstanding_0_Q1_shares":51995349.0,"Assets_0_Q1_USD":640926000.0,"EarningsPerShareDiluted_1_Q1_USD":0.29,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":107098000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":206724000.0,"EarningsPerShareDiluted_2_Q2_USD":0.6,"Assets_0_Q2_USD":660492000.0,"EarningsPerShareBasic_2_Q2_USD":0.6,"StockholdersEquity_0_Q2_USD":602074000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":52019000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":51820000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":52541000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":52591000.0,"NetIncomeLoss_1_Q2_USD":16051000.0,"NetIncomeLoss_2_Q2_USD":31288000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":32583000.0,"CommonStockSharesOutstanding_0_Q2_shares":52081876.0,"EarningsPerShareBasic_1_Q2_USD":0.31,"EarningsPerShareDiluted_1_Q2_USD":0.31,"Ticker":"NEOG","CIK":"711377","name":"NEOGEN CORP","OfficialName":"Neogen Corporation Common Stock","form":"10-Q","period":"20181130","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3158444013.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20181005"}]